nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—CYP1A2—Carmustine—malignant glioma	0.291	0.57	CbGbCtD
Pantoprazole—CYP3A4—Temozolomide—malignant glioma	0.22	0.43	CbGbCtD
Pantoprazole—Omeprazole—CYP2C18—malignant glioma	0.0053	0.522	CrCbGaD
Pantoprazole—Disorder sight—Temozolomide—malignant glioma	0.00505	0.0154	CcSEcCtD
Pantoprazole—Tongue discolouration—Temozolomide—malignant glioma	0.00498	0.0152	CcSEcCtD
Pantoprazole—Lansoprazole—CYP2C18—malignant glioma	0.00484	0.478	CrCbGaD
Pantoprazole—Transaminases increased—Carmustine—malignant glioma	0.00409	0.0125	CcSEcCtD
Pantoprazole—Haemorrhoids—Temozolomide—malignant glioma	0.00409	0.0125	CcSEcCtD
Pantoprazole—Oral candidiasis—Carmustine—malignant glioma	0.00392	0.012	CcSEcCtD
Pantoprazole—Oral candidiasis—Temozolomide—malignant glioma	0.00379	0.0116	CcSEcCtD
Pantoprazole—Hypokinesia—Carmustine—malignant glioma	0.00369	0.0113	CcSEcCtD
Pantoprazole—Thrombosis—Carmustine—malignant glioma	0.00352	0.0107	CcSEcCtD
Pantoprazole—Lung disorder—Temozolomide—malignant glioma	0.0034	0.0104	CcSEcCtD
Pantoprazole—Herpes zoster—Temozolomide—malignant glioma	0.00319	0.00975	CcSEcCtD
Pantoprazole—Abscess—Carmustine—malignant glioma	0.00315	0.0096	CcSEcCtD
Pantoprazole—Coagulopathy—Temozolomide—malignant glioma	0.00309	0.00943	CcSEcCtD
Pantoprazole—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00292	0.00892	CcSEcCtD
Pantoprazole—Speech disorder—Carmustine—malignant glioma	0.00289	0.00883	CcSEcCtD
Pantoprazole—Liver injury—Temozolomide—malignant glioma	0.00286	0.00872	CcSEcCtD
Pantoprazole—Speech disorder—Temozolomide—malignant glioma	0.0028	0.00854	CcSEcCtD
Pantoprazole—Breast pain—Temozolomide—malignant glioma	0.00276	0.00841	CcSEcCtD
Pantoprazole—Thinking abnormal—Carmustine—malignant glioma	0.00272	0.0083	CcSEcCtD
Pantoprazole—Viral infection—Temozolomide—malignant glioma	0.00266	0.00813	CcSEcCtD
Pantoprazole—Leukocytosis—Carmustine—malignant glioma	0.00265	0.00808	CcSEcCtD
Pantoprazole—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00265	0.00807	CcSEcCtD
Pantoprazole—Herpes simplex—Temozolomide—malignant glioma	0.00261	0.00797	CcSEcCtD
Pantoprazole—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00254	0.00776	CcSEcCtD
Pantoprazole—Neck pain—Carmustine—malignant glioma	0.00252	0.00769	CcSEcCtD
Pantoprazole—Injection site reaction—Carmustine—malignant glioma	0.00247	0.00755	CcSEcCtD
Pantoprazole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00241	0.00734	CcSEcCtD
Pantoprazole—Vaginal inflammation—Temozolomide—malignant glioma	0.00241	0.00734	CcSEcCtD
Pantoprazole—Candida infection—Carmustine—malignant glioma	0.00238	0.00725	CcSEcCtD
Pantoprazole—Neuropathy—Carmustine—malignant glioma	0.00234	0.00713	CcSEcCtD
Pantoprazole—Influenza like illness—Temozolomide—malignant glioma	0.00234	0.00713	CcSEcCtD
Pantoprazole—Candida infection—Temozolomide—malignant glioma	0.0023	0.00701	CcSEcCtD
Pantoprazole—Vaginal infection—Temozolomide—malignant glioma	0.00227	0.00693	CcSEcCtD
Pantoprazole—Neuropathy—Temozolomide—malignant glioma	0.00226	0.00689	CcSEcCtD
Pantoprazole—Neoplasm—Carmustine—malignant glioma	0.00225	0.00687	CcSEcCtD
Pantoprazole—Gynaecomastia—Carmustine—malignant glioma	0.00223	0.0068	CcSEcCtD
Pantoprazole—Neoplasm—Temozolomide—malignant glioma	0.00217	0.00664	CcSEcCtD
Pantoprazole—Abnormal vision—Carmustine—malignant glioma	0.00217	0.00663	CcSEcCtD
Pantoprazole—Mental disability—Carmustine—malignant glioma	0.00216	0.00659	CcSEcCtD
Pantoprazole—Sepsis—Carmustine—malignant glioma	0.00216	0.00659	CcSEcCtD
Pantoprazole—Abnormal vision—Temozolomide—malignant glioma	0.0021	0.0064	CcSEcCtD
Pantoprazole—Mental disability—Temozolomide—malignant glioma	0.00209	0.00637	CcSEcCtD
Pantoprazole—Thrombophlebitis—Carmustine—malignant glioma	0.00209	0.00637	CcSEcCtD
Pantoprazole—Diabetes mellitus—Carmustine—malignant glioma	0.00208	0.00634	CcSEcCtD
Pantoprazole—Ear pain—Temozolomide—malignant glioma	0.00205	0.00625	CcSEcCtD
Pantoprazole—Thrombophlebitis—Temozolomide—malignant glioma	0.00202	0.00616	CcSEcCtD
Pantoprazole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00201	0.00613	CcSEcCtD
Pantoprazole—Gastroenteritis—Temozolomide—malignant glioma	0.00197	0.00601	CcSEcCtD
Pantoprazole—Injury—Carmustine—malignant glioma	0.00197	0.006	CcSEcCtD
Pantoprazole—Deafness—Temozolomide—malignant glioma	0.00195	0.00596	CcSEcCtD
Pantoprazole—Hepatic failure—Temozolomide—malignant glioma	0.00194	0.00593	CcSEcCtD
Pantoprazole—Nasal congestion—Temozolomide—malignant glioma	0.00192	0.00585	CcSEcCtD
Pantoprazole—Hot flush—Temozolomide—malignant glioma	0.00187	0.0057	CcSEcCtD
Pantoprazole—Menopausal symptoms—Temozolomide—malignant glioma	0.00185	0.00565	CcSEcCtD
Pantoprazole—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00185	0.00565	CcSEcCtD
Pantoprazole—Thirst—Temozolomide—malignant glioma	0.00183	0.0056	CcSEcCtD
Pantoprazole—Hyponatraemia—Carmustine—malignant glioma	0.00181	0.00554	CcSEcCtD
Pantoprazole—Diplopia—Carmustine—malignant glioma	0.00181	0.00551	CcSEcCtD
Pantoprazole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00181	0.00551	CcSEcCtD
Pantoprazole—Diplopia—Temozolomide—malignant glioma	0.00175	0.00533	CcSEcCtD
Pantoprazole—Face oedema—Carmustine—malignant glioma	0.00174	0.00532	CcSEcCtD
Pantoprazole—Affect lability—Temozolomide—malignant glioma	0.00172	0.00525	CcSEcCtD
Pantoprazole—Face oedema—Temozolomide—malignant glioma	0.00169	0.00514	CcSEcCtD
Pantoprazole—Liver function test abnormal—Carmustine—malignant glioma	0.00167	0.00509	CcSEcCtD
Pantoprazole—Mood swings—Temozolomide—malignant glioma	0.00165	0.00505	CcSEcCtD
Pantoprazole—Dehydration—Temozolomide—malignant glioma	0.00162	0.00496	CcSEcCtD
Pantoprazole—Dry skin—Temozolomide—malignant glioma	0.0016	0.00488	CcSEcCtD
Pantoprazole—Breast disorder—Temozolomide—malignant glioma	0.00158	0.00482	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00157	0.0048	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00157	0.0048	CcSEcCtD
Pantoprazole—Dysphagia—Carmustine—malignant glioma	0.00156	0.00477	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00154	0.0047	CcSEcCtD
Pantoprazole—Abdominal distension—Temozolomide—malignant glioma	0.00152	0.00464	CcSEcCtD
Pantoprazole—Dysphagia—Temozolomide—malignant glioma	0.00151	0.00461	CcSEcCtD
Pantoprazole—Pancytopenia—Carmustine—malignant glioma	0.00148	0.00453	CcSEcCtD
Pantoprazole—Sweating increased—Temozolomide—malignant glioma	0.00147	0.00449	CcSEcCtD
Pantoprazole—Bronchitis—Temozolomide—malignant glioma	0.00145	0.00443	CcSEcCtD
Pantoprazole—Pancytopenia—Temozolomide—malignant glioma	0.00143	0.00437	CcSEcCtD
Pantoprazole—Dysuria—Temozolomide—malignant glioma	0.00141	0.00431	CcSEcCtD
Pantoprazole—Hyperglycaemia—Carmustine—malignant glioma	0.00141	0.0043	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0014	0.00428	CcSEcCtD
Pantoprazole—Pneumonia—Carmustine—malignant glioma	0.0014	0.00427	CcSEcCtD
Pantoprazole—Pollakiuria—Temozolomide—malignant glioma	0.00139	0.00425	CcSEcCtD
Pantoprazole—Erectile dysfunction—Temozolomide—malignant glioma	0.00139	0.00424	CcSEcCtD
Pantoprazole—Depression—Carmustine—malignant glioma	0.00139	0.00424	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.00138	0.0042	CcSEcCtD
Pantoprazole—Weight increased—Temozolomide—malignant glioma	0.00137	0.00419	CcSEcCtD
Pantoprazole—Weight decreased—Temozolomide—malignant glioma	0.00137	0.00417	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Carmustine—malignant glioma	0.00136	0.00417	CcSEcCtD
Pantoprazole—Hyperglycaemia—Temozolomide—malignant glioma	0.00136	0.00415	CcSEcCtD
Pantoprazole—Stomatitis—Carmustine—malignant glioma	0.00136	0.00414	CcSEcCtD
Pantoprazole—Urinary tract infection—Carmustine—malignant glioma	0.00135	0.00413	CcSEcCtD
Pantoprazole—Pneumonia—Temozolomide—malignant glioma	0.00135	0.00413	CcSEcCtD
Pantoprazole—Infestation NOS—Temozolomide—malignant glioma	0.00135	0.00411	CcSEcCtD
Pantoprazole—Infestation—Temozolomide—malignant glioma	0.00135	0.00411	CcSEcCtD
Pantoprazole—Depression—Temozolomide—malignant glioma	0.00134	0.00409	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00133	0.00407	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00132	0.00403	CcSEcCtD
Pantoprazole—Stomatitis—Temozolomide—malignant glioma	0.00131	0.004	CcSEcCtD
Pantoprazole—Urinary tract infection—Temozolomide—malignant glioma	0.00131	0.00399	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.00127	0.00388	CcSEcCtD
Pantoprazole—Sinusitis—Temozolomide—malignant glioma	0.00126	0.00385	CcSEcCtD
Pantoprazole—Haemoglobin—Carmustine—malignant glioma	0.00126	0.00383	CcSEcCtD
Pantoprazole—Haemorrhage—Carmustine—malignant glioma	0.00125	0.00381	CcSEcCtD
Pantoprazole—Hypoaesthesia—Carmustine—malignant glioma	0.00124	0.0038	CcSEcCtD
Pantoprazole—Hallucination—Carmustine—malignant glioma	0.00124	0.0038	CcSEcCtD
Pantoprazole—Oedema peripheral—Carmustine—malignant glioma	0.00123	0.00376	CcSEcCtD
Pantoprazole—Connective tissue disorder—Carmustine—malignant glioma	0.00123	0.00375	CcSEcCtD
Pantoprazole—Haemoglobin—Temozolomide—malignant glioma	0.00121	0.00371	CcSEcCtD
Pantoprazole—Haemorrhage—Temozolomide—malignant glioma	0.00121	0.00369	CcSEcCtD
Pantoprazole—Hepatitis—Temozolomide—malignant glioma	0.00121	0.00369	CcSEcCtD
Pantoprazole—Visual impairment—Carmustine—malignant glioma	0.0012	0.00368	CcSEcCtD
Pantoprazole—Hallucination—Temozolomide—malignant glioma	0.0012	0.00367	CcSEcCtD
Pantoprazole—Hypoaesthesia—Temozolomide—malignant glioma	0.0012	0.00367	CcSEcCtD
Pantoprazole—Pharyngitis—Temozolomide—malignant glioma	0.0012	0.00366	CcSEcCtD
Pantoprazole—Urinary tract disorder—Temozolomide—malignant glioma	0.00119	0.00364	CcSEcCtD
Pantoprazole—Oedema peripheral—Temozolomide—malignant glioma	0.00119	0.00363	CcSEcCtD
Pantoprazole—Connective tissue disorder—Temozolomide—malignant glioma	0.00119	0.00362	CcSEcCtD
Pantoprazole—Urethral disorder—Temozolomide—malignant glioma	0.00118	0.00361	CcSEcCtD
Pantoprazole—Eye disorder—Carmustine—malignant glioma	0.00117	0.00357	CcSEcCtD
Pantoprazole—Visual impairment—Temozolomide—malignant glioma	0.00116	0.00355	CcSEcCtD
Pantoprazole—Flushing—Carmustine—malignant glioma	0.00116	0.00354	CcSEcCtD
Pantoprazole—Erythema multiforme—Temozolomide—malignant glioma	0.00114	0.00349	CcSEcCtD
Pantoprazole—Eye disorder—Temozolomide—malignant glioma	0.00113	0.00345	CcSEcCtD
Pantoprazole—Tinnitus—Temozolomide—malignant glioma	0.00113	0.00344	CcSEcCtD
Pantoprazole—Flushing—Temozolomide—malignant glioma	0.00112	0.00342	CcSEcCtD
Pantoprazole—Arrhythmia—Carmustine—malignant glioma	0.00112	0.00341	CcSEcCtD
Pantoprazole—Alopecia—Carmustine—malignant glioma	0.0011	0.00337	CcSEcCtD
Pantoprazole—Mental disorder—Carmustine—malignant glioma	0.0011	0.00334	CcSEcCtD
Pantoprazole—Immune system disorder—Temozolomide—malignant glioma	0.00109	0.00333	CcSEcCtD
Pantoprazole—Malnutrition—Carmustine—malignant glioma	0.00109	0.00332	CcSEcCtD
Pantoprazole—Chills—Temozolomide—malignant glioma	0.00108	0.00331	CcSEcCtD
Pantoprazole—Alopecia—Temozolomide—malignant glioma	0.00107	0.00326	CcSEcCtD
Pantoprazole—Mental disorder—Temozolomide—malignant glioma	0.00106	0.00323	CcSEcCtD
Pantoprazole—Back pain—Carmustine—malignant glioma	0.00105	0.00321	CcSEcCtD
Pantoprazole—Malnutrition—Temozolomide—malignant glioma	0.00105	0.00321	CcSEcCtD
Pantoprazole—Dysgeusia—Temozolomide—malignant glioma	0.00103	0.00314	CcSEcCtD
Pantoprazole—Vision blurred—Carmustine—malignant glioma	0.00103	0.00313	CcSEcCtD
Pantoprazole—Tremor—Carmustine—malignant glioma	0.00102	0.00311	CcSEcCtD
Pantoprazole—Back pain—Temozolomide—malignant glioma	0.00102	0.0031	CcSEcCtD
Pantoprazole—Anaemia—Carmustine—malignant glioma	0.00101	0.00307	CcSEcCtD
Pantoprazole—Agitation—Carmustine—malignant glioma	0.001	0.00305	CcSEcCtD
Pantoprazole—Vision blurred—Temozolomide—malignant glioma	0.000991	0.00302	CcSEcCtD
Pantoprazole—Tremor—Temozolomide—malignant glioma	0.000985	0.00301	CcSEcCtD
Pantoprazole—Ill-defined disorder—Temozolomide—malignant glioma	0.000976	0.00298	CcSEcCtD
Pantoprazole—Leukopenia—Carmustine—malignant glioma	0.000974	0.00297	CcSEcCtD
Pantoprazole—Anaemia—Temozolomide—malignant glioma	0.000972	0.00297	CcSEcCtD
Pantoprazole—Agitation—Temozolomide—malignant glioma	0.000966	0.00295	CcSEcCtD
Pantoprazole—Angioedema—Temozolomide—malignant glioma	0.000961	0.00293	CcSEcCtD
Pantoprazole—Malaise—Temozolomide—malignant glioma	0.000948	0.00289	CcSEcCtD
Pantoprazole—Vertigo—Temozolomide—malignant glioma	0.000945	0.00288	CcSEcCtD
Pantoprazole—Convulsion—Carmustine—malignant glioma	0.000943	0.00288	CcSEcCtD
Pantoprazole—Leukopenia—Temozolomide—malignant glioma	0.000941	0.00287	CcSEcCtD
Pantoprazole—Hypertension—Carmustine—malignant glioma	0.000939	0.00287	CcSEcCtD
Pantoprazole—Palpitations—Temozolomide—malignant glioma	0.000929	0.00284	CcSEcCtD
Pantoprazole—Myalgia—Carmustine—malignant glioma	0.000926	0.00283	CcSEcCtD
Pantoprazole—Chest pain—Carmustine—malignant glioma	0.000926	0.00283	CcSEcCtD
Pantoprazole—Anxiety—Carmustine—malignant glioma	0.000923	0.00282	CcSEcCtD
Pantoprazole—Cough—Temozolomide—malignant glioma	0.000918	0.0028	CcSEcCtD
Pantoprazole—Convulsion—Temozolomide—malignant glioma	0.000911	0.00278	CcSEcCtD
Pantoprazole—Hypertension—Temozolomide—malignant glioma	0.000908	0.00277	CcSEcCtD
Pantoprazole—Confusional state—Carmustine—malignant glioma	0.000895	0.00273	CcSEcCtD
Pantoprazole—Arthralgia—Temozolomide—malignant glioma	0.000895	0.00273	CcSEcCtD
Pantoprazole—Myalgia—Temozolomide—malignant glioma	0.000895	0.00273	CcSEcCtD
Pantoprazole—Anxiety—Temozolomide—malignant glioma	0.000892	0.00272	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000889	0.00271	CcSEcCtD
Pantoprazole—Oedema—Carmustine—malignant glioma	0.000888	0.00271	CcSEcCtD
Pantoprazole—Discomfort—Temozolomide—malignant glioma	0.000884	0.0027	CcSEcCtD
Pantoprazole—Infection—Carmustine—malignant glioma	0.000882	0.00269	CcSEcCtD
Pantoprazole—Dry mouth—Temozolomide—malignant glioma	0.000875	0.00267	CcSEcCtD
Pantoprazole—Thrombocytopenia—Carmustine—malignant glioma	0.000869	0.00265	CcSEcCtD
Pantoprazole—Tachycardia—Carmustine—malignant glioma	0.000867	0.00265	CcSEcCtD
Pantoprazole—Confusional state—Temozolomide—malignant glioma	0.000865	0.00264	CcSEcCtD
Pantoprazole—Anaphylactic shock—Temozolomide—malignant glioma	0.000858	0.00262	CcSEcCtD
Pantoprazole—Oedema—Temozolomide—malignant glioma	0.000858	0.00262	CcSEcCtD
Pantoprazole—Infection—Temozolomide—malignant glioma	0.000853	0.0026	CcSEcCtD
Pantoprazole—Anorexia—Carmustine—malignant glioma	0.000846	0.00258	CcSEcCtD
Pantoprazole—Nervous system disorder—Temozolomide—malignant glioma	0.000842	0.00257	CcSEcCtD
Pantoprazole—Thrombocytopenia—Temozolomide—malignant glioma	0.00084	0.00256	CcSEcCtD
Pantoprazole—Skin disorder—Temozolomide—malignant glioma	0.000834	0.00254	CcSEcCtD
Pantoprazole—Hypotension—Carmustine—malignant glioma	0.00083	0.00253	CcSEcCtD
Pantoprazole—Hyperhidrosis—Temozolomide—malignant glioma	0.00083	0.00253	CcSEcCtD
Pantoprazole—Anorexia—Temozolomide—malignant glioma	0.000818	0.0025	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000809	0.00247	CcSEcCtD
Pantoprazole—Insomnia—Carmustine—malignant glioma	0.000803	0.00245	CcSEcCtD
Pantoprazole—Paraesthesia—Carmustine—malignant glioma	0.000797	0.00243	CcSEcCtD
Pantoprazole—Dyspnoea—Carmustine—malignant glioma	0.000792	0.00242	CcSEcCtD
Pantoprazole—Somnolence—Carmustine—malignant glioma	0.000789	0.00241	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000782	0.00239	CcSEcCtD
Pantoprazole—Insomnia—Temozolomide—malignant glioma	0.000776	0.00237	CcSEcCtD
Pantoprazole—Decreased appetite—Carmustine—malignant glioma	0.000772	0.00236	CcSEcCtD
Pantoprazole—Paraesthesia—Temozolomide—malignant glioma	0.000771	0.00235	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000767	0.00234	CcSEcCtD
Pantoprazole—Dyspnoea—Temozolomide—malignant glioma	0.000765	0.00234	CcSEcCtD
Pantoprazole—Somnolence—Temozolomide—malignant glioma	0.000763	0.00233	CcSEcCtD
Pantoprazole—Pain—Carmustine—malignant glioma	0.000759	0.00232	CcSEcCtD
Pantoprazole—Constipation—Carmustine—malignant glioma	0.000759	0.00232	CcSEcCtD
Pantoprazole—Dyspepsia—Temozolomide—malignant glioma	0.000755	0.00231	CcSEcCtD
Pantoprazole—Decreased appetite—Temozolomide—malignant glioma	0.000746	0.00228	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000741	0.00226	CcSEcCtD
Pantoprazole—Fatigue—Temozolomide—malignant glioma	0.00074	0.00226	CcSEcCtD
Pantoprazole—Pain—Temozolomide—malignant glioma	0.000734	0.00224	CcSEcCtD
Pantoprazole—Constipation—Temozolomide—malignant glioma	0.000734	0.00224	CcSEcCtD
Pantoprazole—Feeling abnormal—Carmustine—malignant glioma	0.000732	0.00223	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000726	0.00222	CcSEcCtD
Pantoprazole—Feeling abnormal—Temozolomide—malignant glioma	0.000707	0.00216	CcSEcCtD
Pantoprazole—Abdominal pain—Carmustine—malignant glioma	0.000702	0.00214	CcSEcCtD
Pantoprazole—Body temperature increased—Carmustine—malignant glioma	0.000702	0.00214	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000702	0.00214	CcSEcCtD
Pantoprazole—Urticaria—Temozolomide—malignant glioma	0.000682	0.00208	CcSEcCtD
Pantoprazole—Abdominal pain—Temozolomide—malignant glioma	0.000678	0.00207	CcSEcCtD
Pantoprazole—Body temperature increased—Temozolomide—malignant glioma	0.000678	0.00207	CcSEcCtD
Pantoprazole—Hypersensitivity—Carmustine—malignant glioma	0.000654	0.002	CcSEcCtD
Pantoprazole—Asthenia—Carmustine—malignant glioma	0.000637	0.00194	CcSEcCtD
Pantoprazole—Hypersensitivity—Temozolomide—malignant glioma	0.000632	0.00193	CcSEcCtD
Pantoprazole—Asthenia—Temozolomide—malignant glioma	0.000616	0.00188	CcSEcCtD
Pantoprazole—Diarrhoea—Carmustine—malignant glioma	0.000608	0.00185	CcSEcCtD
Pantoprazole—Pruritus—Temozolomide—malignant glioma	0.000607	0.00185	CcSEcCtD
Pantoprazole—Dizziness—Carmustine—malignant glioma	0.000587	0.00179	CcSEcCtD
Pantoprazole—Diarrhoea—Temozolomide—malignant glioma	0.000587	0.00179	CcSEcCtD
Pantoprazole—Dizziness—Temozolomide—malignant glioma	0.000567	0.00173	CcSEcCtD
Pantoprazole—Vomiting—Carmustine—malignant glioma	0.000565	0.00172	CcSEcCtD
Pantoprazole—Rash—Carmustine—malignant glioma	0.00056	0.00171	CcSEcCtD
Pantoprazole—Dermatitis—Carmustine—malignant glioma	0.000559	0.00171	CcSEcCtD
Pantoprazole—Headache—Carmustine—malignant glioma	0.000556	0.0017	CcSEcCtD
Pantoprazole—Vomiting—Temozolomide—malignant glioma	0.000546	0.00167	CcSEcCtD
Pantoprazole—Rash—Temozolomide—malignant glioma	0.000541	0.00165	CcSEcCtD
Pantoprazole—Dermatitis—Temozolomide—malignant glioma	0.000541	0.00165	CcSEcCtD
Pantoprazole—Headache—Temozolomide—malignant glioma	0.000538	0.00164	CcSEcCtD
Pantoprazole—Nausea—Carmustine—malignant glioma	0.000527	0.00161	CcSEcCtD
Pantoprazole—Nausea—Temozolomide—malignant glioma	0.00051	0.00156	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000101	0.000665	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—RTEL1—malignant glioma	0.0001	0.000663	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	9.97e-05	0.000659	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	9.97e-05	0.000659	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	9.92e-05	0.000656	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.92e-05	0.000655	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	9.89e-05	0.000653	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	9.79e-05	0.000647	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—malignant glioma	9.45e-05	0.000624	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—IDH2—malignant glioma	9.29e-05	0.000614	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.2e-05	0.000608	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.99e-05	0.000594	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.9e-05	0.000588	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.76e-05	0.000579	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP2B6—malignant glioma	8.74e-05	0.000577	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—IDH2—malignant glioma	8.6e-05	0.000568	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.39e-05	0.000554	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.12e-05	0.000536	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TNF—malignant glioma	8.1e-05	0.000535	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP2B6—malignant glioma	8.09e-05	0.000534	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	8.05e-05	0.000532	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—IDH1—malignant glioma	7.99e-05	0.000528	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.8e-05	0.000515	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—RTEL1—malignant glioma	7.74e-05	0.000512	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SPHK1—malignant glioma	7.73e-05	0.000511	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7.71e-05	0.000509	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.66e-05	0.000506	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP2C18—malignant glioma	7.57e-05	0.0005	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.55e-05	0.000499	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—IDH1—malignant glioma	7.4e-05	0.000489	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—COX8A—malignant glioma	7.4e-05	0.000489	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—COX8A—malignant glioma	7.22e-05	0.000477	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.17e-05	0.000474	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SPHK1—malignant glioma	7.16e-05	0.000473	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.14e-05	0.000472	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP2C18—malignant glioma	7.01e-05	0.000463	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	6.96e-05	0.00046	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.94e-05	0.000458	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—COX8A—malignant glioma	6.74e-05	0.000445	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.61e-05	0.000437	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	6.57e-05	0.000434	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.51e-05	0.00043	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ASMT—malignant glioma	6.29e-05	0.000415	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.28e-05	0.000415	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.23e-05	0.000412	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.15e-05	0.000406	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.14e-05	0.000406	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ASMT—malignant glioma	6.14e-05	0.000405	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.14e-05	0.000405	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTT1—malignant glioma	6.13e-05	0.000405	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.12e-05	0.000404	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.06e-05	0.0004	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.03e-05	0.000398	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.92e-05	0.000391	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BCAN—malignant glioma	5.91e-05	0.000391	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BCAN—malignant glioma	5.77e-05	0.000381	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—COX8A—malignant glioma	5.76e-05	0.000381	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS1—malignant glioma	5.74e-05	0.000379	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ASMT—malignant glioma	5.73e-05	0.000379	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.72e-05	0.000378	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTT1—malignant glioma	5.67e-05	0.000375	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.63e-05	0.000372	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.6e-05	0.00037	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.5e-05	0.000363	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BCAN—malignant glioma	5.39e-05	0.000356	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.36e-05	0.000354	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—BCHE—malignant glioma	5.34e-05	0.000353	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS1—malignant glioma	5.32e-05	0.000351	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC5A5—malignant glioma	5.27e-05	0.000348	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.16e-05	0.000341	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.15e-05	0.00034	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.99e-05	0.000329	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—BCHE—malignant glioma	4.94e-05	0.000326	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.94e-05	0.000326	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ASMT—malignant glioma	4.9e-05	0.000324	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC5A5—malignant glioma	4.88e-05	0.000322	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.86e-05	0.000321	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.79e-05	0.000316	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—IDH2—malignant glioma	4.77e-05	0.000315	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.66e-05	0.000308	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—IDH2—malignant glioma	4.65e-05	0.000307	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BCAN—malignant glioma	4.61e-05	0.000304	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.5e-05	0.000297	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.49e-05	0.000297	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2B6—malignant glioma	4.48e-05	0.000296	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—COX8A—malignant glioma	4.45e-05	0.000294	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2B6—malignant glioma	4.37e-05	0.000289	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—IDH2—malignant glioma	4.35e-05	0.000287	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.31e-05	0.000285	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.29e-05	0.000284	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTP1—malignant glioma	4.25e-05	0.000281	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.2e-05	0.000277	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CAT—malignant glioma	4.13e-05	0.000273	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—IDH1—malignant glioma	4.1e-05	0.000271	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.1e-05	0.000271	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.09e-05	0.00027	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—IDH1—malignant glioma	4e-05	0.000264	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4e-05	0.000264	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.97e-05	0.000262	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SPHK1—malignant glioma	3.97e-05	0.000262	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTP1—malignant glioma	3.93e-05	0.00026	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NCOR1—malignant glioma	3.9e-05	0.000258	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.89e-05	0.000257	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SPHK1—malignant glioma	3.87e-05	0.000256	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CAT—malignant glioma	3.83e-05	0.000253	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2C18—malignant glioma	3.79e-05	0.000251	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ASMT—malignant glioma	3.78e-05	0.00025	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—IDH1—malignant glioma	3.74e-05	0.000247	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—IDH2—malignant glioma	3.71e-05	0.000245	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.66e-05	0.000242	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.64e-05	0.000241	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SPHK1—malignant glioma	3.62e-05	0.000239	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NCOR1—malignant glioma	3.61e-05	0.000239	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BCAN—malignant glioma	3.56e-05	0.000235	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.54e-05	0.000234	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.52e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.5e-05	0.000231	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.49e-05	0.000231	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.34e-05	0.000221	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.34e-05	0.00022	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.22e-05	0.000213	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—IDH1—malignant glioma	3.19e-05	0.000211	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CAV1—malignant glioma	3.18e-05	0.00021	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—malignant glioma	3.14e-05	0.000208	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SPHK1—malignant glioma	3.09e-05	0.000204	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—malignant glioma	3.07e-05	0.000203	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.04e-05	0.000201	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.04e-05	0.000201	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.03e-05	0.0002	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.98e-05	0.000197	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CAV1—malignant glioma	2.95e-05	0.000195	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS1—malignant glioma	2.94e-05	0.000195	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.94e-05	0.000194	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.93e-05	0.000194	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—malignant glioma	2.9e-05	0.000191	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS1—malignant glioma	2.87e-05	0.00019	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH2—malignant glioma	2.87e-05	0.000189	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—malignant glioma	2.86e-05	0.000189	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.85e-05	0.000189	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPARG—malignant glioma	2.8e-05	0.000185	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BCHE—malignant glioma	2.74e-05	0.000181	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.7e-05	0.000179	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.69e-05	0.000178	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS1—malignant glioma	2.68e-05	0.000177	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—malignant glioma	2.68e-05	0.000177	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.67e-05	0.000177	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BCHE—malignant glioma	2.67e-05	0.000176	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC5A5—malignant glioma	2.64e-05	0.000174	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.6e-05	0.000172	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPARG—malignant glioma	2.59e-05	0.000171	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.56e-05	0.000169	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—malignant glioma	2.55e-05	0.000168	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.53e-05	0.000167	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.51e-05	0.000166	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BCHE—malignant glioma	2.5e-05	0.000165	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.47e-05	0.000163	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH1—malignant glioma	2.46e-05	0.000163	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—malignant glioma	2.45e-05	0.000162	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.43e-05	0.000161	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SPHK1—malignant glioma	2.38e-05	0.000158	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—malignant glioma	2.36e-05	0.000156	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.34e-05	0.000154	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.33e-05	0.000154	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.31e-05	0.000153	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS1—malignant glioma	2.29e-05	0.000152	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.29e-05	0.000151	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—malignant glioma	2.22e-05	0.000147	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.21e-05	0.000146	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—malignant glioma	2.2e-05	0.000145	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—malignant glioma	2.18e-05	0.000144	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BCHE—malignant glioma	2.13e-05	0.000141	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—malignant glioma	2.13e-05	0.00014	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CAT—malignant glioma	2.12e-05	0.00014	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.11e-05	0.000139	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAT—malignant glioma	2.07e-05	0.000137	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—malignant glioma	2.06e-05	0.000136	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—malignant glioma	2.04e-05	0.000135	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.01e-05	0.000133	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOR1—malignant glioma	2e-05	0.000132	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.99e-05	0.000132	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—malignant glioma	1.99e-05	0.000131	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.97e-05	0.00013	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOR1—malignant glioma	1.95e-05	0.000129	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAT—malignant glioma	1.93e-05	0.000128	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—malignant glioma	1.92e-05	0.000127	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—malignant glioma	1.89e-05	0.000125	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOR1—malignant glioma	1.82e-05	0.000121	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—malignant glioma	1.78e-05	0.000117	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS1—malignant glioma	1.77e-05	0.000117	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.72e-05	0.000114	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—malignant glioma	1.7e-05	0.000112	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAT—malignant glioma	1.65e-05	0.000109	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BCHE—malignant glioma	1.65e-05	0.000109	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CAV1—malignant glioma	1.63e-05	0.000108	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.63e-05	0.000107	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAV1—malignant glioma	1.59e-05	0.000105	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOR1—malignant glioma	1.56e-05	0.000103	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.56e-05	0.000103	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAV1—malignant glioma	1.49e-05	9.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.49e-05	9.82e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—malignant glioma	1.45e-05	9.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARG—malignant glioma	1.43e-05	9.48e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.42e-05	9.39e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARG—malignant glioma	1.4e-05	9.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.36e-05	8.95e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.35e-05	8.94e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—malignant glioma	1.31e-05	8.65e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARG—malignant glioma	1.31e-05	8.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.31e-05	8.63e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—malignant glioma	1.28e-05	8.42e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAT—malignant glioma	1.27e-05	8.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAV1—malignant glioma	1.27e-05	8.4e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—malignant glioma	1.25e-05	8.28e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.21e-05	8.02e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOR1—malignant glioma	1.2e-05	7.95e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.19e-05	7.87e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.16e-05	7.65e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.14e-05	7.52e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—malignant glioma	1.13e-05	7.45e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARG—malignant glioma	1.12e-05	7.38e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—malignant glioma	1.11e-05	7.34e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—malignant glioma	1.11e-05	7.3e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—malignant glioma	1.1e-05	7.28e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.04e-05	6.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—malignant glioma	1.03e-05	6.8e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—malignant glioma	1.02e-05	6.76e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.02e-05	6.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—malignant glioma	9.84e-06	6.5e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAV1—malignant glioma	9.81e-06	6.48e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—malignant glioma	9.6e-06	6.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—malignant glioma	8.97e-06	5.93e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.94e-06	5.9e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.87e-06	5.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—malignant glioma	8.79e-06	5.81e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARG—malignant glioma	8.63e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.86e-06	5.19e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—malignant glioma	7.67e-06	5.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—malignant glioma	6.94e-06	4.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.85e-06	4.52e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—malignant glioma	6.78e-06	4.48e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—malignant glioma	6.78e-06	4.48e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.33e-06	4.18e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—malignant glioma	5.92e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—malignant glioma	5.67e-06	3.75e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—malignant glioma	5.53e-06	3.66e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.41e-06	3.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—malignant glioma	5.17e-06	3.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—malignant glioma	4.42e-06	2.92e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.17e-06	2.76e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—malignant glioma	3.41e-06	2.25e-05	CbGpPWpGaD
